Extendicare Total Cash From Operating Activities from 2010 to 2026
| EXE Stock | CAD 26.64 0.46 1.76% |
Total Cash From Operating Activities | First Reported 2003-03-31 | Previous Quarter 63.9 M | Current Value 30.8 M | Quarterly Volatility 20.9 M |
Review Extendicare financial statements over time to add context on performance and capital structure. It connects Depreciation And Amortization of 44.4 M, Interest Expense of 30.7 M or Total Revenue of 1.2 B and ratios such as Price To Sales Ratio of 1.15, Dividend Yield of 0.0217 or PTB Ratio of 5.13 with Extendicare Valuation and Volatility context.
Extendicare | Total Cash From Operating Activities |
Evaluating Extendicare's Total Cash From Operating Activities across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Extendicare's fundamental strength.
Latest Extendicare's Total Cash From Operating Activities Growth Pattern
Below is the plot of the Total Cash From Operating Activities of Extendicare over the last few years. It is Extendicare's Total Cash From Operating Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Extendicare's overall financial position and show how it may be relating to other accounts over time.
| Total Cash From Operating Activities | 10 Years Trend |
|
Total Cash From Operating Activities |
| Timeline |
Extendicare Total Cash From Operating Activities Regression Statistics
| Arithmetic Mean | 84,677,674 | |
| Coefficient Of Variation | 57.91 | |
| Mean Deviation | 39,934,281 | |
| Median | 85,607,000 | |
| Standard Deviation | 49,040,984 | |
| Sample Variance | 2405T | |
| Range | 173.8M | |
| R-Value | 0.35 | |
| Mean Square Error | 2256.2T | |
| R-Squared | 0.12 | |
| Significance | 0.17 | |
| Slope | 3,371,305 | |
| Total Sum of Squares | 38480.3T |
Extendicare Total Cash From Operating Activities History
Extendicare Valuation Metrics
Extendicare is a large-cap equity in Health Care Providers & Services, Health Care Equipment & Services, Health Care categories. Intrinsic value assumptions are benchmarked against sector averages. This analysis reviews how Extendicare integrates into a multi-asset portfolio across market cycles.
Methodology
Unless otherwise specified, financial data for Extendicare is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Extendicare (CA:EXE) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA) as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Extendicare may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
Pair Trading with Extendicare
Pair trading with Extendicare can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.
Moving together with Extendicare Stock
Moving against Extendicare Stock
Using correlated positions as Extendicare substitutes during tax-loss harvesting allows investors to capture a tax benefit without disrupting portfolio allocation. The key is finding instruments that track Extendicare closely enough to maintain equivalent risk and return.
The correlation of Extendicare with other assets is a key diversification metric. Pairing Extendicare with uncorrelated or negatively correlated instruments can reduce overall portfolio volatility without necessarily reducing expected returns.
Correlation analysis and pair trading evaluation for Extendicare can be used to frame hedging context. The view can be extended across sectors or other related groups.More Resources for Extendicare Stock Analysis
Other Information on Investing in Extendicare Stock
Extendicare financial ratios help frame valuation context across profits, cash flow, and enterprise value. They help compare Extendicare across measures in a consistent way.